AngioDynamics, Inc.

NasdaqGS:ANGO Stock Report

Market Cap: US$282.0m

AngioDynamics Future Growth

Future criteria checks 3/6

AngioDynamics is forecast to grow earnings and revenue by 95.2% and 7.1% per annum respectively while EPS is expected to grow by 95.5% per annum.

Key information

95.2%

Earnings growth rate

95.5%

EPS growth rate

Medical Equipment earnings growth17.4%
Revenue growth rate7.1%
Future return on equityn/a
Analyst coverage

Low

Last updated04 Oct 2024

Recent future growth updates

AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Jul 19
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Recent updates

AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Jul 19
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

Jul 18
Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

AngioDynamics: A Story To Monitor

May 14

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 09

AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

Apr 06
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

AngioDynamics: Restructuring Initiative May Not Go Far Enough

Jan 14

AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 12
AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

Mar 31
AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance

Oct 06

AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold

Sep 29

Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

Sep 02
Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M

Jul 12

Earnings and Revenue Growth Forecasts

NasdaqGS:ANGO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
5/31/2027343-2N/AN/A1
5/31/2026306-28N/AN/A3
5/31/2025284-39N/AN/A3
8/31/2024293-243-27-21N/A
5/31/2024304-184-34-28N/A
2/29/2024324-192-23-17N/A
11/30/2023330-14-7-3N/A
8/31/20233366-5-1N/A
5/31/2023339-52-40N/A
2/28/2023335-37-12-7N/A
11/30/2022328-33-22-17N/A
8/31/2022321-33-28-23N/A
5/31/2022316-27-11-7N/A
2/28/2022306-40-7-4N/A
11/30/2021303-38711N/A
8/31/2021298-341621N/A
5/31/2021291-321924N/A
2/28/2021273-1691016N/A
11/30/2020271-171-14-8N/A
8/31/2020268-170-21-13N/A
5/31/2020264-167-22-15N/A
2/29/2020277-707N/A
11/30/2019273-62733N/A
8/31/2019273-73640N/A
5/31/2019271-113437N/A
2/28/2019205-343336N/A
11/30/2018223-162832N/A
8/31/2018240-122629N/A
5/31/2018262-6N/A41N/A
2/28/20183431N/A37N/A
11/30/2017345-10N/A47N/A
8/31/20173474N/A51N/A
5/31/2017270-7N/A56N/A
2/28/2017356-25N/A55N/A
11/30/2016358-27N/A53N/A
8/31/2016357-42N/A48N/A
5/31/2016351-44N/A45N/A
2/29/2016347-1N/A37N/A
11/30/2015346-6N/A37N/A
8/31/2015349-5N/A25N/A
5/31/2015352-3N/A26N/A
2/28/2015356-4N/A25N/A
11/30/20143585N/A12N/A
8/31/20143544N/A23N/A
5/31/20143512N/A25N/A
2/28/20143462N/A26N/A
11/30/2013340-3N/A37N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ANGO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: ANGO is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ANGO is expected to become profitable in the next 3 years.

Revenue vs Market: ANGO's revenue (7.1% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: ANGO's revenue (7.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ANGO's Return on Equity is forecast to be high in 3 years time


Discover growth companies